Showing results (111-120 of 144) with videos related to

Sort By:
Pageof 15
The Journal of Investigative Dermatology|November 4, 2018
Atopic Dermatitis in America Study: A Cross-Sectional Study Examining the Prevalence and Disease Burden of Atopic Dermatitis in the US Adult PopulationZelma C Chiesa Fuxench, Julie K Block, Mark Boguniewicz, et al.
Pediatric Dermatology|March 8, 2026
Long-Term Safety and Efficacy of Once-Daily and Proactive Twice-Weekly Roflumilast Cream 0.05% for Mild-to-Moderate Atopic Dermatitis in Children Aged 2-5 Years From a 52-Week, Phase 3 Trial (INTEGUMENT-OLE)Lawrence F Eichenfield, Mercedes E Gonzalez, Mark Boguniewicz, et al.
The Journal of Investigative Dermatology|November 25, 2011
Genetic variants in interferon regulatory factor 2 (IRF2) are associated with atopic dermatitis and eczema herpeticumPei-Song Gao, Donald Y M Leung, Nicholas M Rafaels, et al.
The Journal of Allergy and Clinical Immunology|September 8, 2009
Filaggrin mutations that confer risk of atopic dermatitis confer greater risk for eczema herpeticumPei-Song Gao, Nicholas M Rafaels, Tracey Hand, et al.
Pediatrics|March 25, 2015
Safety and efficacy of pimecrolimus in atopic dermatitis: a 5-year randomized trialBardur Sigurgeirsson, Andrzej Boznanski, Gail Todd, et al.
The Journal of Allergy and Clinical Immunology|February 5, 2013
Atopic dermatitis: a practice parameter update 2012Lynda Schneider, Stephen Tilles, Peter Lio, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 23, 2023
Dupilumab Inhibits Vascular Leakage of Blood Proteins Into Atopic Dermatitis SkinDonald Y M Leung, Robert Bissonnette, Simion Kreimer, et al.
Allergy|July 11, 2022
Dupilumab significantly improves skin barrier function in patients with moderate-to-severe atopic dermatitisEvgeny Berdyshev, Elena Goleva, Robert Bissonnette, et al.
Dermatology and Therapy|June 2, 2025
Rapid Itch Improvement and Skin Clearance with Upadacitinib Versus Placebo (Measure Up 1 and Measure Up 2) and Versus Dupilumab (Heads Up): Results from Three Phase 3 Clinical Trials in Patients with Moderate-to-Severe Atopic DermatitisEric L Simpson, Jonathan I Silverberg, Vimal H Prajapati, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 14, 2023
Phenotypic and Endotypic Determinants of Atopic Dermatitis Severity From the Atopic Dermatitis Research Network (ADRN) RegistryEric L Simpson, Anna De Benedetto, Mark Boguniewicz, et al.
Pageof 15